USPTO serial 99426428
CELLSIGHT
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CELLSIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Whitelaw
Jennifer Whitelaw WHITELAW LEGAL GROUP3838 Tamiami Trail North, Suite 310Naples, FL 34103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable webinars in the field of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Downloadable electronic publications in the nature of newsletters and abstracts in the field of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Downloadable computer software for scientific analysis of genetic sequences; Downloadable computer software for accessing, reading, and tracking information in the field of medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of enhancing the analysis of research, and managing the review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis on a blockchain; Downloadable computer software for medical diagnosis, testing, and analysis of medical test results; Downloadable medical software for medical diagnosis, testing, and analysis of medical test results | ACTIVE | — |
| 042 | Medical and scientific research information in the field of human disease and human medical conditions; Scientific research; Scientific research for medical purposes in the field of human disease and human medical conditions; Medical research in the field of infectious diseases; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Medical research laboratory services in the field of oncology; Providing information on clinical studies via an interactive website; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Medical and scientific research consulting services for others in the field of design, planning, and implementation project management of scientific testing and research and clinical scientific testing; Developing customized web pages and other data feed formats featuring user-defined information in the field of scientific testing and research, medical research, and clinical scientific testing; Providing temporary use of non-downloadable cloud-based software for the management of scientific testing and research, medical research, and clinical scientific testing; Providing online non-downloadable computer networking software; Providing on-line non-downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis using blockchain technology; Software as a service (SAAS) services in the nature of hosting cloud-based software of others; Software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; Genetic mapping for scientific purposes; DNA sequencing technology research; Medical research services in the field of cancer; Research in the field of cytogenetics; Laboratory services for the production of chemotherapy drugs in the nature of clinical study and testing of cells, cell analysis and cell preservation; Research and development in the field of medical scientific research, particularly in relation to gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; Providing scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer | ACTIVE | — |
| 044 | Medical information; Medical diagnostic services; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Providing medical information in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; Medical information services provided via the Internet; Providing medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cancer Cell Diagnostics, Inc.
- Other trademarks owned by Cancer Cell Diagnostics, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELLSIGHT
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 25, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 25, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |